World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
59144
World Ranking
4479
National Ranking
2437

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Melanoma, Cancer research, Pathology, Metastasis and Cancer are his primary areas of study. His specific area of interest is Melanoma, where Dave S.B. Hoon studies Cutaneous melanoma. The various areas that Dave S.B. Hoon examines in his Cancer research study include DNA methylation, Oncogene, Messenger RNA, microRNA and Tumor progression.

His research in Pathology intersects with topics in Colorectal cancer, Antigen, Sentinel node and Polymerase chain reaction. The study incorporates disciplines such as Sentinel lymph node, MART-1 Antigen, Lymphadenectomy, Lymph and Chemokine receptor in addition to Metastasis. His Cancer research includes themes of Gene silencing, Gene, Oncology and Bioinformatics.

His most cited work include:

  • Cell-free nucleic acids as biomarkers in cancer patients (1731 citations)
  • A landscape of driver mutations in melanoma (1701 citations)
  • Genomic Classification of Cutaneous Melanoma (1491 citations)

What are the main themes of his work throughout his whole career to date?

Dave S.B. Hoon focuses on Melanoma, Cancer research, Pathology, Cancer and Internal medicine. His studies in Melanoma integrate themes in fields like Tumor progression, Metastasis, Immunology and Immunotherapy. He interconnects DNA methylation, Molecular biology and Epigenetics, microRNA, Gene in the investigation of issues within Cancer research.

His Pathology study integrates concerns from other disciplines, such as Stage and Colorectal cancer. His Cancer research incorporates themes from Nucleic acid, DNA and Bioinformatics. His biological study spans a wide range of topics, including Endocrinology, Surgery and Oncology.

He most often published in these fields:

  • Melanoma (45.26%)
  • Cancer research (42.58%)
  • Pathology (27.01%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer research (42.58%)
  • Melanoma (45.26%)
  • Cancer (26.76%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cancer research, Melanoma, Cancer, DNA methylation and Internal medicine. His Cancer research research is multidisciplinary, incorporating elements of Cell growth, Immune system and Regulation of gene expression, Epigenetics, Gene. The Melanoma study combines topics in areas such as Pathology, Metastasis, Brain metastasis and Immunotherapy.

The study incorporates disciplines such as Blockade, Biopsy and Immunology in addition to Cancer. His studies in DNA methylation integrate themes in fields like Chromatin and Methylation. His Internal medicine study deals with Oncology intersecting with Biomarker, Cohort, Disease and Urine.

Between 2014 and 2021, his most popular works were:

  • Genomic Classification of Cutaneous Melanoma (1491 citations)
  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma (543 citations)
  • Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA (393 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Dave S.B. Hoon spends much of his time researching Cancer research, Melanoma, Cancer, Gene and Oncology. His Cancer research research incorporates themes from DNA methylation, Carcinogenesis, Immune system, microRNA and Drug resistance. He studies Cutaneous melanoma, a branch of Melanoma.

His research in Cancer intersects with topics in Biopsy, Immunology and DNA sequencing. His Gene research entails a greater understanding of Genetics. His Oncology study combines topics from a wide range of disciplines, such as Missense mutation, Colon adenocarcinoma, Pathology and Biomarker, Internal medicine.

Best Publications

  • Cell-free nucleic acids as biomarkers in cancer patients

    Heidi Schwarzenbach;Dave S. B. Hoon;Klaus Pantel

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • A landscape of driver mutations in melanoma

    Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA

    Richard B. Lanman;Stefanie A. Mortimer;Oliver A. Zill;Dragan Sebisanovic

  • Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer

    Sota Asaga;Christine Kuo;Tung Nguyen;Marilou Terpenning

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

    D. S. B. Hoon;Yuan Wang;P. S. Dale;A. J. Conrad

  • Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

    Peter J. Bostick;Sunanda Chatterjee;Dorcas D. Chi;Kelly T. Huynh

  • Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum

    Naoyuki Umetani;Armando E. Giuliano;Suzanne H. Hiramatsu;Farin Amersi

  • Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival

    Joseph Kim;Hiroya Takeuchi;Stella T. Lam;Roderick R. Turner

  • Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

    D L Morton;L J Foshag;D S Hoon;J A Nizze

  • Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

    Yusuke Sato;Yasufumi Goto;Norihiko Narita;Dave S.B. Hoon

  • Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats

    Naoyuki Umetani;Joseph Kim;Suzanne Hiramatsu;Howard A. Reber

  • Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.

    Donald L. Morton;Dave S.B. Hoon;Alistair J. Cochran;Roderick R. Turner

Frequent Co-Authors

Donald L. Morton
Donald L. Morton Saint John's Health Center
Armando E. Giuliano
Armando E. Giuliano Cedars-Sinai Medical Center
He-Jing Wang
He-Jing Wang University of California, Los Angeles
David Elashoff
David Elashoff University of California, Los Angeles
Steven J. O'Day
Steven J. O'Day St. John's University
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Alistair J. Cochran
Alistair J. Cochran University of California, Los Angeles
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
James S. Wilmott
James S. Wilmott University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA is no longer limited to traditional, in-person programs. Many students are now exploring online degrees that offer flexibility, affordability, and diverse entry points—especially in nursing. If you’re considering advancing your nursing credentials while managing other responsibilities, online options provide a practical solution.

For those seeking advanced practice and leadership roles, there are cheapest dnp programs online that deliver high-quality education at a lower cost. Registered Nurses can also boost their qualifications without leaving their jobs through cheapest accredited online rn to bsn programs.

If you hold a non-nursing bachelor’s degree but want to transition into nursing, consider direct entry msn programs that get you started quickly. Additionally, students seeking a smoother admission path into nursing school may prefer direct admit nursing programs.

These online and direct admission pathways open doors to rewarding healthcare careers, accommodating varied backgrounds and goals.

Best Scientists Citing Dave S.B. Hoon

Trending Scientists

Recently Published Articles